I disagree. Huimanigan management had greed come into play with their decisions. They could have partnered with a larger pharma to conduct the studies. They made a choice to go it alone. Sample sizes were too small and when the government decided to do a study, the sample size was also small and the virus mutated to a less lethal form. HGEN's management blew their opportunity.
HGEn needs to leave covid alone. The government will not approve Lenz for the use of covid and big pharma will not allow a micro biotech to be successful alone.
Market Data 
Markets 
AI
